HomeEKSO • NASDAQ
add
Ekso Bionics Holdings Inc
Nakaraang pagsara
$0.64
Sakop ng araw
$0.61 - $0.67
Sakop ng taon
$0.50 - $2.35
Market cap
13.88M USD
Average na Volume
2.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
NVDA
16.86%
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 4.13M | -10.38% |
Gastos sa pagpapatakbo | 4.85M | -10.01% |
Net na kita | -2.07M | 38.42% |
Net profit margin | -50.18 | 31.30% |
Kita sa bawat share | — | — |
EBITDA | -2.23M | 10.97% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 8.29M | -16.55% |
Kabuuang asset | 29.21M | -6.33% |
Kabuuang sagutin | 14.34M | -9.96% |
Kabuuang equity | 14.87M | — |
Natitirang share | 22.00M | — |
Presyo para makapag-book | 0.95 | — |
Return on assets | -23.48% | — |
Return on capital | -33.02% | — |
Cash Flow
Net change in cash
(USD) | Set 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -2.07M | 38.42% |
Cash mula sa mga operasyon | -2.28M | 32.09% |
Cash mula sa pag-invest | -8.00K | 52.94% |
Cash mula sa financing | 4.69M | — |
Net change in cash | 2.41M | 171.42% |
Malayang cash flow | -1.11M | 57.80% |
Tungkol
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Ekso Bionics currently focuses in the health and industrial sectors.
The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
CEO
Itinatag
2005
Headquarters
Website
Mga Empleyado
70